HALO
NASDAQ HealthcareHalozyme Therapeutics, Inc. - Common Stock
Biotechnology
📊 Market Data
| Price | $63.56 |
|---|---|
| Volume | 2,092,683 |
| Market Cap | 7.50B |
| Beta | 1.020 |
| RSI (14-Day) | 17.7 Oversold |
| 200-Day MA | $66.61 |
| 50-Day MA | $72.24 |
| 52-Week High | $82.22 |
| 52-Week Low | $47.50 |
| P/E Ratio | 24.83 |
| Forward P/E | 6.45 |
| Price / Book | 153.53 |
🎯 Investment Strategy Scores
How HALO scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
25/100
High dividend yield + low volatility
🚀 Moon Shot
74/100
High growth potential (high beta + oversold)
🔪 Falling Knife
77/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
9/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
68/100
Large-cap, institutional-quality stocks
Find HALO in your text
Paste any text on the homepage — the tool will extract HALO and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.